Company
Bicara Therapeutics Inc. (BCAX)
Standardized SEC financial data for Bicara Therapeutics Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0002023658 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-34.4%
Free cash flow
-$107.1M
Current ratio
14.58×
EPS (diluted)
$-2.52
Income statement
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| R&D expense | $30.6M | $63.6M | — |
| SG&A expense | $9.3M | $18.8M | $30.5M |
| Operating income | -$39.9M |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $4.2M | $230.4M | $489.7M | $414.8M |
| Total current assets | — | $231.1M | $502.5M | $422.1M |
Cash flow
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$45.6M | -$74.8M | -$106.8M |
| Capital expenditures | $586K | $71K | $280K |
| Free cash flow | -$46.2M | -$74.8M |
Get BCAX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BCAX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BCAX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"